A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

CompletedOBSERVATIONAL

Enrollment

2,313

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

April 23, 2024

Study Completion Date

April 23, 2024

Conditions

Prostatic Neoplasms

Interventions

DRUG

Novel hormonal therapy

As provided in real-world setting

Trial Locations (1)

Pfizer Inc, New York